Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio

[1]  D. Visvikis,et al.  Advanced Monte Carlo simulations of emission tomography imaging systems with GATE , 2021, Physics in medicine and biology.

[2]  K. Nakajima,et al.  Calibrated scintigraphic imaging procedures improve quantitative assessment of the cardiac sympathetic nerve activity , 2020, Scientific Reports.

[3]  Kesava S. Kalluri,et al.  Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT , 2019, Physics in medicine and biology.

[4]  K. Nakajima,et al.  Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions , 2019, Journal of movement disorders.

[5]  J. O'Brien,et al.  Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age , 2019, Journal of Nuclear Cardiology.

[6]  K. Nakajima,et al.  Phase dyssynchrony and 123I-meta-iodobenzylguanidine innervation imaging towards standardization , 2019, Journal of Nuclear Cardiology.

[7]  T. Asada,et al.  123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  K. Nakajima,et al.  Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera , 2017, Annals of Nuclear Medicine.

[9]  K. Nakajima,et al.  Standardization of 123I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications , 2017, Clinical and Translational Imaging.

[10]  T. Nakata,et al.  Cardiac sympathetic nervous system imaging with 123I-meta-iodobenzylguanidine: Perspectives from Japan and Europe , 2017, Journal of Nuclear Cardiology.

[11]  K. Nakajima,et al.  A European myocardial 123I-mIBG cross-calibration phantom study , 2017, Journal of Nuclear Cardiology.

[12]  K. Nakajima,et al.  The time has come to standardize 123I-MIBG heart-to-mediastinum ratios including planar and SPECT methods , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  T. Asada,et al.  Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study , 2015, PloS one.

[14]  H. Verberne,et al.  For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. , 2014, European heart journal cardiovascular Imaging.

[15]  K. Nakajima,et al.  Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations , 2014, Journal of Nuclear Cardiology.

[16]  T. Nakata,et al.  A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. , 2013, JACC. Cardiovascular imaging.

[17]  Jeroen J. Bax,et al.  Reproducibility of planar 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  S. Orimo,et al.  123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. , 2012, Parkinsonism & related disorders.

[19]  G. Treglia,et al.  MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis , 2012, Clinical Autonomic Research.

[20]  K. Nakajima,et al.  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[21]  M. Cerqueira,et al.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[22]  Thomas Lengauer,et al.  Permutation importance: a corrected feature importance measure , 2010, Bioinform..

[23]  Kenichi Nakajima,et al.  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function , 2010, Annals of nuclear medicine.

[24]  W. Burchert,et al.  I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  K. Nakajima,et al.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[26]  J Taki,et al.  Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD , 2006, Neurology.

[27]  S. Orimo,et al.  123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[28]  M. Ljungberg,et al.  A Monte Carlo program for the simulation of scintillation camera characteristics. , 1989, Computer methods and programs in biomedicine.

[29]  R. Spielmann,et al.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[30]  K. Nakajima,et al.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study , 2011, European Journal of Nuclear Medicine and Molecular Imaging.